A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004)
A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004)
Active, not recruiting · NCT06688058 · Registry updated 2026-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004) | Healthy | Active, not recruiting | Phase 1 | 2026-03-13 | NCT06688058 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alliance for Multispecialty Research, LLC ( Site 0003) | Kansas City | United States | 1 |
| Alliance for Multispecialty Research, LLC ( Site 0004) | Knoxville | United States | 1 |
| Research Centers of America ( Hollywood ) ( Site 0001) | Hollywood | United States | 2 |
| Velocity Clinical Research, Savannah ( Site 0005) | Savannah | United States | 1 |